View in EDS HTML Full Text PDF Full Text

Tocilizumab in hospitalized patients with COVID-19: Clinical outcomes, inflammatory marker kinetics, and safety.

Saved in:
Bibliographic Details
Title: Tocilizumab in hospitalized patients with COVID-19: Clinical outcomes, inflammatory marker kinetics, and safety.
Authors: Hill JA; Department of Medicine, University of Washington, Seattle, Washington, USA.; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA., Menon MP; Department of Medicine, University of Washington, Seattle, Washington, USA.; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA., Dhanireddy S; Department of Medicine, University of Washington, Seattle, Washington, USA., Wurfel MM; Department of Medicine, University of Washington, Seattle, Washington, USA., Green M; Department of Medicine, University of Washington, Seattle, Washington, USA., Jain R; Department of Medicine, University of Washington, Seattle, Washington, USA.; University of Washington School of Pharmacy, Seattle, Washington, USA., Chan JD; Department of Medicine, University of Washington, Seattle, Washington, USA.; University of Washington School of Pharmacy, Seattle, Washington, USA., Huang J; Department of Medicine, University of Washington, Seattle, Washington, USA.; University of Washington School of Pharmacy, Seattle, Washington, USA., Bethune D; University of Washington School of Medicine, Seattle, Washington, USA., Turtle C; Department of Medicine, University of Washington, Seattle, Washington, USA.; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA., Johnston C; Department of Medicine, University of Washington, Seattle, Washington, USA.; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA., Xie H; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA., Leisenring WM; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA., Nina Kim H; Department of Medicine, University of Washington, Seattle, Washington, USA., Cheng GS; Department of Medicine, University of Washington, Seattle, Washington, USA.; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.
Source: Journal of medical virology [J Med Virol] 2021 Apr; Vol. 93 (4), pp. 2270-2280. Date of Electronic Publication: 2020 Nov 22.
Publication Type: Journal Article; Observational Study
Journal Info: Publisher: Wiley-Liss Country of Publication: United States NLM ID: 7705876 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1096-9071 (Electronic) Linking ISSN: 01466615 NLM ISO Abbreviation: J Med Virol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 33200828
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Tocilizumab in hospitalized patients with COVID-19: Clinical outcomes, inflammatory marker kinetics, and safety.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Hill+JA%22">Hill JA</searchLink>; Department of Medicine, University of Washington, Seattle, Washington, USA.; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.<br /><searchLink fieldCode="AU" term="%22Menon+MP%22">Menon MP</searchLink>; Department of Medicine, University of Washington, Seattle, Washington, USA.; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.<br /><searchLink fieldCode="AU" term="%22Dhanireddy+S%22">Dhanireddy S</searchLink>; Department of Medicine, University of Washington, Seattle, Washington, USA.<br /><searchLink fieldCode="AU" term="%22Wurfel+MM%22">Wurfel MM</searchLink>; Department of Medicine, University of Washington, Seattle, Washington, USA.<br /><searchLink fieldCode="AU" term="%22Green+M%22">Green M</searchLink>; Department of Medicine, University of Washington, Seattle, Washington, USA.<br /><searchLink fieldCode="AU" term="%22Jain+R%22">Jain R</searchLink>; Department of Medicine, University of Washington, Seattle, Washington, USA.; University of Washington School of Pharmacy, Seattle, Washington, USA.<br /><searchLink fieldCode="AU" term="%22Chan+JD%22">Chan JD</searchLink>; Department of Medicine, University of Washington, Seattle, Washington, USA.; University of Washington School of Pharmacy, Seattle, Washington, USA.<br /><searchLink fieldCode="AU" term="%22Huang+J%22">Huang J</searchLink>; Department of Medicine, University of Washington, Seattle, Washington, USA.; University of Washington School of Pharmacy, Seattle, Washington, USA.<br /><searchLink fieldCode="AU" term="%22Bethune+D%22">Bethune D</searchLink>; University of Washington School of Medicine, Seattle, Washington, USA.<br /><searchLink fieldCode="AU" term="%22Turtle+C%22">Turtle C</searchLink>; Department of Medicine, University of Washington, Seattle, Washington, USA.; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.<br /><searchLink fieldCode="AU" term="%22Johnston+C%22">Johnston C</searchLink>; Department of Medicine, University of Washington, Seattle, Washington, USA.; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.<br /><searchLink fieldCode="AU" term="%22Xie+H%22">Xie H</searchLink>; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.<br /><searchLink fieldCode="AU" term="%22Leisenring+WM%22">Leisenring WM</searchLink>; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.<br /><searchLink fieldCode="AU" term="%22Nina+Kim+H%22">Nina Kim H</searchLink>; Department of Medicine, University of Washington, Seattle, Washington, USA.<br /><searchLink fieldCode="AU" term="%22Cheng+GS%22">Cheng GS</searchLink>; Department of Medicine, University of Washington, Seattle, Washington, USA.; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%227705876%22">Journal of medical virology</searchLink> [J Med Virol] 2021 Apr; Vol. 93 (4), pp. 2270-2280. <i>Date of Electronic Publication: </i>2020 Nov 22.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Observational Study
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Wiley-Liss%22">Wiley-Liss </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>7705876 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1096-9071 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2201466615%22">01466615 </searchLink><i>NLM ISO Abbreviation: </i>J Med Virol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=33200828
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1002/jmv.26674
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 2270
    Titles:
      – TitleFull: Tocilizumab in hospitalized patients with COVID-19: Clinical outcomes, inflammatory marker kinetics, and safety.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Hill JA
      – PersonEntity:
          Name:
            NameFull: Menon MP
      – PersonEntity:
          Name:
            NameFull: Dhanireddy S
      – PersonEntity:
          Name:
            NameFull: Wurfel MM
      – PersonEntity:
          Name:
            NameFull: Green M
      – PersonEntity:
          Name:
            NameFull: Jain R
      – PersonEntity:
          Name:
            NameFull: Chan JD
      – PersonEntity:
          Name:
            NameFull: Huang J
      – PersonEntity:
          Name:
            NameFull: Bethune D
      – PersonEntity:
          Name:
            NameFull: Turtle C
      – PersonEntity:
          Name:
            NameFull: Johnston C
      – PersonEntity:
          Name:
            NameFull: Xie H
      – PersonEntity:
          Name:
            NameFull: Leisenring WM
      – PersonEntity:
          Name:
            NameFull: Nina Kim H
      – PersonEntity:
          Name:
            NameFull: Cheng GS
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 04
              Text: 2021 Apr
              Type: published
              Y: 2021
          Identifiers:
            – Type: issn-electronic
              Value: 1096-9071
          Numbering:
            – Type: volume
              Value: 93
            – Type: issue
              Value: 4
          Titles:
            – TitleFull: Journal of medical virology
              Type: main
ResultId 1